The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease

Life Sciences

Volumn 88, Issue 19-20, 2011, Pages 879-885

  Baraka, Azza M ^a   Korish, Aida A ^a   Soliman, Gehan A ^a   Kamal, Hanan ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

6 hydroxydopamine; Parkinsonism; Raloxifene; Selective estrogen receptor modulators; Tamoxifen

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; CASPASE 3; DIARYLPROPIONITRILE; DOPAMINE; ESTRADIOL; GLUTATHIONE PEROXIDASE; HOMOVANILLIC ACID; OXIDOPAMINE; RALOXIFENE; TAMOXIFEN; TAMOXIFEN CITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; NERVE CELL NECROSIS; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OVARIECTOMY; OXIDATIVE STRESS; PARKINSON DISEASE; RAT;

ANIMALS; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; OVARIECTOMY; PARKINSON DISEASE; RATS; RATS, WISTAR; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

ANIMALIA; RATTUS;

EID: 79955525132     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.03.010     Document Type: Article

References (59)

1. R.A. Alyea, S.E. Laurence, S.H. Kim, B.S. Katzenellenbogen, J.A. Katzenellenbogen, and C.S. Watson The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells J Neurochem 106 4 2008 1525 1533
2. M. Arvin, L. Fedorkova, K.A. Disshon, D.E. Dluzen, and R.E. Leipheimer Estrogen modulates responses of striatal dopamine neurons to MPP (+): evaluations using in vitro and in vivo techniques Brain Res 872 2000 160 171 (Pubitemid 30618899)
3. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, and R. Sadoul Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog Neurobiol 65 2001 135 172 (Pubitemid 32524182)
4. M. Bourque, D.E. Dluzen, and T. DiPaolo Neuroprotective actions of sex steroids in Parkinson's disease Front Neuroendocrinol 30 2 2009 142 157
5. M. Cyr, F. Calon, M. Morissette, and T. Di Paolo Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease J Psychiatry Neurosci 27 1 2002 12 27 (Pubitemid 34478366)
6. M. D'Astous, M. Morissette, and T. Di Paolo Effect of estrogen receptor agonists treatment in MPTP mice: evidence of neuroprotection by an ER alpha agonist Neuropharmacology 47 8 2004 1180 1188 (Pubitemid 39572709)
7. M. D'Astous, K.R. Mickley, D.E. Dluzen, and T. Di Paolo Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice Neuroendocrinology 82 2 2005 111 120
8. M.J. DeVito, and G.C. Wagner Methamphetamine induced neuronal damage: a possible role for free radicals Neuropharmacology 28 1989 1145 1150 (Pubitemid 19254411)
9. K.M. Dhandapani, and D.W. Brann Protective effects of estrogen and selective estrogen receptor modulators in the brain Biol Reprod 67 2002 1379 1385 (Pubitemid 35204912)
10. P. Diel Tissue-specific estrogenic response and molecular mechanisms Toxicol Lett 127 1-3 2002 217 224 (Pubitemid 34615513)
11. K.A. Disshon, J.W. Boja, and D.E. Dluzen Inhibition of striatal dopamine transporter activity by 17beta-estradiol Eur J Pharmacol 345 2 1989 207 211
12. D.E. Dluzen, and J.L. McDermott Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease J Gend Specif Med 3 2000 36 42
13. D.E. Dluzen, J.L. McDermott, and L.I. Anderson Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system Neurotox Res 3 3 2001 291 300 (Pubitemid 32962891)
14. L.L. Doncarlos, I. Azcoitia, and L.M. Garcia-Segura Neuroprotective actions of selective estrogen receptor modulators Psychoneuroendocrinology 34 Suppl 1 2009 S113 S122
15. X. Gao, and D.E. Dluzen Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system Neuroscience 103 2 2001 385 394 (Pubitemid 32201925)
16. M. Grandbois, M. Morissette, S. Callier, and T. Di Paolo Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice Neuroreport 11 2000 343 346 (Pubitemid 30074646)
17. R.E. Hruska, and E.K. Silbergeld Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model Science 208 4 1980 1466 1468 (Pubitemid 10022194)
18. O. Imamov, G.J. Shim, M. Warner, and J.A. Gustafsson Estrogen receptor beta in health and disease Biol Reprod 73 5 2005 866 871 (Pubitemid 41507488)
19. M.L. Johnson, C.C. Ho, A.E. Day, Q.D. Walker, R. Francis, and C.M. Kuhn Estrogen receptors enhance dopamine neurone survival in rat midbrain J Neuroendocrinol 22 4 2010 226 237
20. V.C. Jordan, and B.W. O'Malley Selective estrogen-receptor modulators and antihormonal resistance in breast cancer J Clin Oncol 25 36 2007 5815 5824
21. G.G. Kuiper, B. Carlsson, K. Grandien, E. Enmark, J. Häggblad, and S. Nilsson Comparison of the ligand binding specificity and transcript distribution of estrogen receptors α and β Endocrinology 138 1997 863 870 (Pubitemid 27089735)
22. R. Kumar, A.K. Agarwal, and P.K. Seth Free radical-generated neurotoxicity of 6-hydroxydopamine J Neurochem 64 1995 1703 1707
23. M. Landry, D. Lévesque, and T. Di Paolo Estrogenic properties of raloxifene, but not tamoxifen, on D2 and D3 dopamine receptors in the rat forebrain Neuroendocrinology 76 4 2002 214 222 (Pubitemid 36151491)
24. J.C. Latourelle, M. Dybdahl, A.L. Destefano, R.H. Myers, and T.L. Lash Risk of Parkinson's disease after tamoxifen treatment BMC Neurol 10 2010 23
25. M. Le Saux, and T. Di Paolo Influence of oestrogenic compounds on monoamine transporters in rat striatum J Neuroendocrinol 18 1 2006 25 32
26. C.S. Lee, H. Sauer, and A. Bjorklund Dopaminergic neuronal degeneration and motor impairment following axon terminal lesions by intrastriatal 6-OHDA in the rats Neuroscience 72 1996 641 653 (Pubitemid 26124689)
27. G.S. Lee, H.J. Kim, Y.W. Jung, K.C. Choi, and E.B. Jeung Estrogen receptor alpha pathway is involved in the regulation of Calbindin-D9k in the uterus of immature rats Toxicol Sci 84 2 2005 270 277
28. C. Leranth, R.H. Roth, J.D. Elsworth, F. Naftolin, T.L. Horvath, and D.E. Redmond Jr. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory J Neurosci 20 2000 8604 8609
29. X.L. Li, W.D. Cheng, J. Li, X.L. Guo, C.J. Guo, and X.H. Meng Protective effect of estrogen on apoptosis in a cell culture model of Parkinson's disease Clin Invest Med 31 5 2008 E258 E264
30. B. Liu, and D.E. Dluzen Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice Neuroendocrinology 83 5-6 2006 295 302 (Pubitemid 44729787)
31. B. Liu, and D.E. Dluzen Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease Clin Exp Pharmacol Physiol 34 7 2007 555 565 (Pubitemid 46953100)
32. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1 1951 265 275
33. V. Mann, C. Huber, G. Kogianni, F. Collins, and B. Noble The antioxidant effect of estrogen and selective estrogen receptor modulators in the inhibition of osteocyte apoptosis in vitro Bone 40 2007 674 684 (Pubitemid 46201947)
34. S. McArthur, H.E. Murray, A. Dhankot, D.T. Dexter, and G.E. Gillies Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition J Neurochem 100 3 2007 678 692 (Pubitemid 46095618)
35. B. McEwen Estrogen actions throughout the brain Recent Prog Horm Res 57 2002 357 384
36. M.J. Meyers, J. Sun, K.E. Carlson, G.A. Marriner, B.S. Katzenellenbogen, and J.A. Katzenellenbogen Estrogen receptor-β potency selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues J Med Chem 44 2001 4230 4251 (Pubitemid 33095330)
37. C. Monville, E.M. Torres, and S.B. Dunnett Validation of the L-dopa-induced dykinesia in the 6-OHDA model and evaluation of the effects of selective dopamine agonists and antagonists Brain Res Bull 68 1-2 2005 16 23 (Pubitemid 41698872)
38. M. Morissette, and T. Di Paolo Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites J Neurochem 60 2006 1876 1883
39. M. Morissette, and T. Di Paolo Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys J Neurosci Res 87 7 2009 1634 1644
40. M. Morissette, S. Al Sweidi, S. Callier, and T. Di Paolo Estrogen and SERM neuroprotection in animal models of Parkinson's disease Mol Cell Endocrinol 290 1-2 2008 60 69
41. Y. Muramatsu, and T. Araki Glial cells as a target for the development of new therapies for treating Parkinson's disease Drug News Perspect 15 9 2002 586 590 (Pubitemid 36025545)
42. J. Nielsen, G. Mor, and F. Naftolin Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the Fas/Fas ligand system J Neurobiol 43 2000 64 78 (Pubitemid 30191181)
43. M. Olsson, G. Nikkhah, C. Bentlage, and A. Björklund Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test J Neurosci 15 5 Pt 2 1995 3863 3875 May
44. K. Paech, P. Webb, G.G. Kuiper, S. Nilsson, J. Gustafsson, and P.J. Kushner Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites Science 277 5331 1997 1508 1510 (Pubitemid 27449239)
45. G. Paxinos, and C. Watson The rat brain in steriotaxic coordinates 2nd ed. 1986 Academic Press San Diego, CA
46. L.J. Pelligrino, A.S. Pelligrino, and A.J. Cushman A stereotaxic atlas of the rat brain 1981 Plenum Press NY
47. T. Schaller, M.D. Ryck, I.Q. Whishaw, V.D. Ramirez, and P. Teitelbaum Excessive bracing reactions and their control by atropine and L-dopa in an animal analog of Parkinsonism Exp Neurol 64 1979 33 43 (Pubitemid 9185685)
48. P.J. Shughrue Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERa and ERb) Exp Neurol 190 2004 468 477 (Pubitemid 39505000)
49. S.R. Stauffer, C.J. Coletta, R. Tedesco, G. Nishiguchi, K. Carlson, and J. Sun Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-a-selective agonists J Med Chem 43 2000 4934 4947 (Pubitemid 32040974)
50. K.H. Taber, D.D. Murphy, M.M. Blurton-Jones, and R.A. Hurley An update on estrogen: higher cognitive function, receptor mapping, neurotrophic effects J Neuropsychiatry Clin Neurosci 13 3 2001 313 317 (Pubitemid 32743708)
51. W. Tripanichkul, K. Sripanichkulchai, J.A. Duce, and D.I. Finkelstein 17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult Brain Res 1164 2007 24 31 (Pubitemid 47198221)
52. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res 24 1970 485 493
53. L. Wang, S. Andersson, M. Warner, and J.A. Gustafsson Estrogen receptor (ER) beta knockout mice reveal a role for ER beta in migration of cortical neurons in the developing brain Proc Natl Acad Sci USA 100 2003 703 708 (Pubitemid 36126116)
54. R. Wheeler, A.S. Jhaine, M.N. Elsayeed, T.S. Omaye, and J.W.D. Korte Automated assays for superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase activity Anal Biochem 184 1990 193 199
55. J.H. Xar Biostatistical analysis 2nd edition 1984 Prentice Hall Inc Englewood Cliffs, New Jersey 152 183
56. H. Yuan, S. Sarre, G. Ebinger, and Y. Michotte Histological, behavioural and neurochemical evaluation of medical forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease J Neurosci Methods 144 1 2005 35 45 (Pubitemid 40546300)
57. J.Q. Zhang, W.Q. Cai, B.Y. Su, and D.S. Zhou Immunocytochemical localization of estrogen receptor beta in the rat brain Shi Yan Sheng Wu Xue Bao 35 2002 15 20
58. L. Zhao, and R.D. Brinton Estrogen receptor [alpha] and [beta] differentially regulate intracellular Ca2+ dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons Brain Res 1172 2007 48 59 (Pubitemid 47417943)
59. W. Zhou, N. Koldzic-Zivanovic, C.H. Clarke, R. de Beun, K. Wassermann, and P.S. Bury Selective estrogen receptor modulator effects in the rat brain Neuroendocrinology 75 1 2002 24 33 (Pubitemid 34124214)